Phatisa’s acquisition of 100% stake in Deltamune’s operations

Lead party: Phatisa Group Limited (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Deltamune (Pty) Limited (private company) · Sector: Healthcare, Biotechnology, Pharmaceuticals · Countries of operation: South Africa Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity, Natural Resources · Strategy: Secondary Sale · Instrument: Equity ·…


Lead party: Phatisa Group Limited (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Deltamune (Pty) Limited (private company) · Sector: Healthcare, Biotechnology, Pharmaceuticals · Countries of operation: South Africa

Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity, Natural Resources · Strategy: Secondary Sale · Instrument: Equity · Equity stake: 1% · Fund: Phatisa Food Fund 2

Lead investor/buyer: Phatisa Group Limited · Investors/buyers: Phatisa Group Limited · Sellers: HL Hall & Sons Investments

Legal advisers: not identified in the source record.

Source: announced 14 January 2022. Original announcement: phatisa.com.